4D Molecular Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FDMT and other ETFs, options, and stocks.About FDMT
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution.
CEODavid H. Kirn
CEODavid H. Kirn
Employees227
Employees227
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2013
Founded2013
Employees227
Employees227
FDMT Key Statistics
Market cap602.78M
Market cap602.78M
Price-Earnings ratio-2.57
Price-Earnings ratio-2.57
Dividend yield—
Dividend yield—
Average volume811.86K
Average volume811.86K
High today$10.61
High today$10.61
Low today$10.11
Low today$10.11
Open price$10.19
Open price$10.19
Volume102.44K
Volume102.44K
52 Week high$12.34
52 Week high$12.34
52 Week low$2.24
52 Week low$2.24
Stock Snapshot
As of today, 4D Molecular Therapeutics(FDMT) shares are valued at $10.55. The company's market cap stands at 602.78M, with a P/E ratio of -2.57.
On 2025-12-03, 4D Molecular Therapeutics(FDMT) stock moved within a range of $10.11 to $10.61. With shares now at $10.55, the stock is trading +4.4% above its intraday low and -0.6% below the session's peak.
Trading activity shows a volume of 102.44K, compared to an average daily volume of 811.86K.
Over the past 52 weeks, 4D Molecular Therapeutics(FDMT) stock has traded between a high of $12.34 and a low of $2.24.
Over the past 52 weeks, 4D Molecular Therapeutics(FDMT) stock has traded between a high of $12.34 and a low of $2.24.
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
People also own
Based on the portfolios of people who own FDMT. This list is generated using Robinhood data, and it’s not a recommendation.